Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
3b Future Health Fund S.A. Sicar investment portfolio
3b Future Health Fund S.A. Sicar has made numerous investments in companies such as Utility Therapeutics, Neophore, and Quantumdx Group within the Healthcare & Life Sciences sector.
vc
Portfolio
3
Team
0
Portfolio (3)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Neophore Limited NeoPhore Ltd develops small‑molecule immuno‑oncology therapies that transiently inhibit DNA mismatch‑repair proteins to generate tumour neo‑antigens and enhance response to immune‑checkpoint blockade, focusing on cancer patients who are not responsive to existing immunotherapies. | Healthcare & Life Sciences | Altrincham | Confirmed | 2026-05-08 |
| Quantumdx Group Limited QuantuMDx Group Limited develops and sells the Q‑POC™ platform, a rapid, multiplex molecular diagnostic system that delivers lab‑standard results in minutes for use at the point of care, targeting clinicians and healthcare providers for infections such as STIs and antimicrobial resistance. | Healthcare & Life Sciences | Newcastle Upon Tyne | Confirmed | 2026-03-04 |
Backs Similar Companies
Investors who tend to invest in the same sort of companies.
5 more similar investors hiddenSign up to unlock →
Shareholding changes (4)
3b Future Health Fund S.A. Sicar's positions across portfolio companies2026
- ORDINARY 197,290 → 0
- B1 ORDINARY 65,339 → 0
- B2 ORDINARY 76,565 → 0
- B3 ORDINARY 44,824 → 0